Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARTA: Prolonged vs Standard DAPT after XINSORB BRS
NCT04501900Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Oct 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD), myocardial infarction (MI), sponsored by Zhongshan Hospital, Fudan University. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)myocardial infarction (MI)
Beyond the preview
Go deeper on NCT04501900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501900.